Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Sema4

Biotech & Life Sciences · Stamford, United States · Founded 2017 Unicorn

Health intelligence company and a leader in diagnostic testing

Valuation
$2.00B
Market cap · 2026
Revenue
$306M
Latest reported FY

Investors

8 investors on Sema4's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 8 investors entered at this stage
Oak HC/FT
Moore Strategic Ventures
Blackstone
Section 32
Decheng Capital
BlackRock
Deerfield
Connecticut Innovations

Global footprint

Where Sema4 has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
180 monthly visits
across markets
🇺🇸 United States111.1%
Top 1 markets shown

Patent intelligence

$32k patent portfolio · 4 active families

Estimated portfolio value
$32k
<0.01% of market cap · 1086.7× smaller than top peer Veracyte ($35M)
4 active patent families
Where Sema4 innovates PathologyBioinformaticsOncologyData miningCiliated cell

Where Sema4 concentrates vs peers

Each axis is a top-10 topic across Sema4 and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Sema4

An AI-synthesized read of the highest-engagement posts about Sema4 on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sema4 on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.